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ABSTRACT: Payers are seeking new ways to bring rapidly increasing health care costs under 
control. In the past five years, health plans have implemented a variety of programs, the most 
visible of which have been pay-for-performance, public reporting (PR), consumer-directed health 
plans (CDHP), and tiering. This paper reviews the emerging concerns about measurement 
programs generally and specific assessments of the above four types in particular. The authors 
express considerable concern about the utility of programs focused on judgment (PR, CDHP, and 
tiering). As an alternative, they encourage the use of programs focused on quality improvement. 
Judgment-based programs undermine collaboration among stakeholders, making it more difficult 
to implement the system-wide changes that are needed to significantly improve the value of care. 
Quality-improvement approaches, tied to incentives and accountability, offer a more constructive 
model for an effective and efficient health care system. 
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 EXECUTIVE SUMMARY 
 
In their efforts to improve health care system efficiency, payers have become 
increasingly active in promoting strategies to improve the value of care. While initially 
focusing on quality, in order to address their continuing increases in costs of care, payers 
have recently added cost or efficiency measures to their programs. This paper reviews the 
four most popular strategies to address cost and efficiency: pay-for-performance, public 
reporting, consumer-directed health plans, and tiered or limited networks. 
 
We begin by considering the strengths and weaknesses of the current methods of 
collecting and interpreting cost efficiency data, reporting results to interested parties, and 
providing incentives to shape provider behavior and patient outcomes. We then examine 
the four specific strategies in detail. 
 
General Measurement Issues 
Accuracy 
The current trend in efficiency measurement is to calculate an index of physicians’ costs 
relative to those of their peers. Efficiency indexes are built on the assumption that 
underlying claims data are correct, but there are a number of problems with that 
assumption. For example, on their visit billing forms, the doctors may use disease 
descriptions but not diagnostic codes. If the doctor writes, for example, “depression,” a 
clerk must later decide whether this means minor depression, major depression, psychotic 
depression, reactive depression, or adjustment disorder with depressed mood, all of which 
are coded differently. In addition, because of the complex insurer–hospital contracts, 
which include payment formulas tied to volume and sites of service, the cost of any single 
hospitalization or procedure may be difficult or impossible to calculate. The result is 
estimated costs that may not accurately incorporate facility costs into the overall cost 
calculation. In episodes of care that involve hospitalization, those hospitalization costs are 
often a major determinant of total episode costs. The accuracy of each health plan’s 
management of data is also crucial to reporting validity and should be transparent to the 
subjects of the reporting (i.e., providers) and those using the data to make decisions. 
 
Attribution 
There are many ways to assign a patient’s costs to a practitioner, practice group, or 
integrated system, whether for population- or episode-based measures. In fact, different 
attribution rules can result in significantly different conclusions. Recent data suggest that 
some beneficiaries change assigned physicians from one year to the next, making 
assignment by individual physician inaccurate. Determining how patients’ costs are 
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 assigned may influence how some clinical decisions will be made and the degree to which 
physicians are likely to effectively collaborate. For example, if assignment of costs is based 
on the physician with the highest cost in the episode of care, the collaborating physicians 
will have incentive to have others order expensive tests. If, instead, all the physicians who 
contribute to more than 30 percent of the overall costs are assigned the cost of the episode, 
all the involved physicians will have incentive to talk with each other about how to 
minimize unnecessary care and costs. 
 
Assignment of Cost 
Practitioners reasonably argue that they can only be held accountable for the costs that 
they themselves engender. However, scoring on these direct or responsible costs creates an 
incentive to make other practitioners order the more expensive interventions, such as 
medications, imaging, consultations, or hospitalizations. This approach can cause delays in 
appropriate care because of disagreements over who should prescribe chronic medication 
refills or who should order an indicated MRI. 
 
Incentive Program Goal 
Stakeholders debate whether an efficiency measure should pay for achieving a target or for 
significant improvement. Those arguing for reaching targets say that to deliver true quality 
care, a particular level of care must be assured. Therefore, they conclude, one should be 
rewarded for reaching that target. On the other hand, if one employs an all-or-none 
model, those who were top performers before creating the incentive are rewarded, 
discouraging the lowest performers from investing in an improvement program with a 
target they are unlikely to reach, and encouraging providers to preferentially select patients 
already close to the target. 
 
Actionability 
For efficiency-reporting programs to be successful they must predictably pinpoint 
practitioners’ overuse and misuse behaviors, those that add cost but do not improve 
desired outcomes. Simply providing a global rolled-up measure, such as a cost-efficiency 
index that compares them to a specialty average, is itself inefficient. For the busy 
practitioner, trying to find what to do differently—without the proper tools—results in 
wasted time, frustration, and, eventually, a lack of trust in the sponsoring organization. 
Meanwhile, in trying to become more efficient and improve their scores, they may reduce 
their treatment of necessary as well as unnecessary services. Finally, if the desired action is 
to move patients from less efficient to more efficient practitioners, program administrators 
should be certain there is excess capacity in the more-efficient group to accommodate the 
shift. If there is not capacity in the “more-efficient” group, patients will have to pay a 
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 higher copay for care that is ranked as less-effective care. That situation can only lead to 
frustration and raise patients’ concerns about their physicians’ quality. 
 
Pay-for-Performance 
Pay-for-performance is designed to provide a direct link between payment and the 
performance of carefully selected services. The measures selected are intended to evaluate the 
practitioners’ performance on certain combinations of cost/efficiency, quality, and a patient’s 
experience of care. Although there is growing acceptance of pay-for-performance programs, 
its influence has been hampered by small incentives, lack of adequate post-intervention 
follow-up, and methodological problems with collecting and reporting the data. 
 
We believe that insurers will come to understand that rather than unsuccessfully 
attempting to identify and reward the best practitioners, the most productive use of pay-
for-performance programs is promoting behavioral change for a small set of carefully 
selected measures for which there is ample evidence of need for improvement. Organizing 
the professional community around a specific set of behaviors that are known to have a 
direct impact on outcomes creates incentive to improve. Although there is concern about 
incentives diverting attention from nonselected activities, if the measures chosen are of 
significant benefit, the time focused on them would be well spent. 
 
Public Reporting 
Public reports are designed to drive system change in three ways: using comparison 
data to motivate providers to improve performance, stimulating payers to reward quality 
and efficiency, and providing information to patients so that they can choose their care 
more wisely. 
 
But physicians tend to see the public reporting of their individual quality and cost 
data as misleading and even threatening. Their concerns about accuracy, sufficient sample 
size, and the inherent judgment imposed by forced rankings—seemingly to motivate 
physicians to change through fear of humiliation or shame—put the intent of public 
reporting programs into question. 
 
Data should of course be available to consumers to allow them to decide from 
whom to seek care and what outcomes they may expect. The challenge, however, is to 
present the data in a way that minimizes the judging of physicians and focuses on 
encouraging quality improvement. Prematurely providing misleading or insufficient 
information to consumers risks alienating practitioners while offering no real benefit 
to patients. 
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 Consumer-Directed Health Plans (CDHP) 
All variations of CDHP try to offer consumers broad choices of providers and services, 
coupled with greater information about—and liability for—their prices. In theory, if there 
is access to information on cost, care options, quality, and risks, patients will act as 
informed consumers in a competitive market, helping to manage their costs by taking 
more responsibility for their health care decisions. 
 
But CDHP depends on patients’ proper interpretation of reported data, an area in 
which even physicians have difficulty. Even more important, there is good evidence that 
patient cost-sharing can actually decrease the quality of care. As a patient’s cost increases, 
fewer services, appropriate along with inappropriate, tend to be used. 
 
Meanwhile, physicians are deeply concerned that they will spend valuable time 
looking up comparative fees, become more involved in negotiating rates, and have higher 
office expenses as bills are increasingly collected from patients’ health savings accounts or 
out-of-pocket. To many practitioners, this model increases rather than decreases system 
inefficiencies. This is especially true now, when the data available to patients is simply 
inadequate to reliably improve decision-making. 
 
Tiered and Limited Networks 
Tiered networks utilize two mechanisms for controlling cost. The first is to encourage 
patients to switch from lower-value to higher-value physicians by offering lower copays 
for higher-value physicians or higher copays for lower-value physicians. The second 
mechanism is to encourage physicians to become more cost efficient in order to avoid the 
negative outcomes of being advertised as a lower-tier physician, with an attendant loss 
of patients. 
 
Unfortunately, the criteria for selection in tiers can vary significantly. Selection is 
confounded, moreover, by issues related to geographic needs and sociodemographic 
variables, making the validity of these forced rankings suspect. 
 
One obvious limitation of these approaches is access to providers. The concept of 
restricting access to a subset of providers necessarily implies that there is a pool of excess 
high-value providers from which to choose in that geographical area. In many 
communities, this is simply not the case, especially in rural and some inner-city areas. 
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 Conclusions 
The lack of demonstrated efficacy, the problems with trying to identify the precise 
qualities of a physician that lead to predictable increases in health care value, and the 
inherently judgmental nature of these four strategies suggest that public reporting, tiered 
and limited networks, and pay-for-performance programs that try to judge the overall 
quality of a physician are unlikely to fulfill their expectations. Results to date lead us to 
conclude that, in the health care industry, basing change on the foundation of win–lose 
relationships does not work. As we look to create a more effective and efficient health care 
system, it is critical that we not mistake programs to force behavioral change with 
successful quality-improvement processes. 
 
In such a process, the physician’s behavior is seen as contributing to a system of 
care. As that system is evaluated for how it delivers services, behaviors that help or hinder 
the attainment of desired outcomes may be identified. By focusing on specific units of 
behaviors rather than critiquing the overall performance of one individual physician, the 
focus remains on the need to improve rather than on placing blame. 
 
We believe that the current focus on judgment programs has accomplished little 
and will continue to meet with limited success. These programs ignore some of the more 
important lessons that the business community has learned about true quality 
improvement. Successful improvement is rooted in partnership based on a commitment to 
achieve mutually agreed upon goals and a sense of shared benefit. Transparency must be 
delivered not only in the data reported to patients and purchasers but also in the processes 
that health plans use to make decisions about physician performance. 
 
Successful transformation of our present system to one based on value requires the 
collaboration of multiple stakeholders. We focus on collaboration because effective 
partnerships are needed to effectively coordinate behaviors, provide a continuum of 
services, and ensure that evidence and patient-centeredness underlie medical decision-
making. The current medical system’s silos must be broken down and replaced with 
integrated programs that encourage and reward effective and efficient system solutions. 
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 CURRENT APPROACHES TO IMPROVING 
THE VALUE OF CARE: A PHYSICIAN’S PERSPECTIVE 
 
Dr. Sara Jerome is a 38-year-old family physician who lives in a community of 40,000 
people. She works three days a week and carries a panel of 1,500 patients. She has two 
partners, each of whom works three days a week as well. The group employs Paul, a nurse 
practitioner who works five half-days a week. All four share after-hours call. Dr. Jerome 
admits patients to the university hospital 40 minutes away, where they are cared for by a 
hospitalist. Sicker patients are often transported there by ambulance. When her patients are 
discharged, about 70 percent of the time she receives information about final diagnoses, 
discharge medications, results of tests ordered, and suggestions for follow-up care. 
The group employs five full-time office staff. John is the billing clerk/practice 
manager who has worked at the practice for 10 years. Yvonne is the receptionist, also on the 
job for 10 years, and Judy, George, and Becky are technicians who assist with patient care, 
call in refills, answer patient questions, and supply handouts requested by the practitioners. 
Last week, Dr. Jerome received a “physician profile” from the dominant health plan 
in her community. A major element of the profile was an index of her relative cost-efficiency, 
adjusted for her case mix by episode-of-care methodology. She found the index hard to 
understand but thinks it reported that she cost 10 percent more than other plan doctors. An 
attached “drill-down” sheet suggested that Dr. Jerome’s higher expense resulted from her care 
of patients with diabetes, depression, heart failure, and esophagitis. Within these conditions, 
it appeared that facility costs were the dominant cost factor in her diabetes and heart-failure 
cases, medication prescribing was responsible for her costliness in esophagitis, and professional 
services were responsible for her increased costs in depression. Her patient-satisfaction and 
quality scores were above average, earning congratulations from the plan. 
 
 
 
 
 
INTRODUCTION 
In their efforts to improve system efficiency, payers have recently been taking cost 
measures, along with the traditional quality measures, into account—as in the above 
example. Physician behavior may be influenced both by financial and nonfinancial 
incentives.1,2,3 This paper will review the four most popular strategies currently being 
promoted: pay-for-performance, public reporting, consumer-directed health plans, and 
tiered or limited networks. 
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 We begin by discussing the general strengths and weaknesses of collecting and 
interpreting data, presenting the results to interested parties, and providing incentives for 
provider behavior and outcomes. We then examine the strategies of pay-for-performance, 
public reporting, consumer-directed health care, and tiered or limited networks in some 
detail. We describe the logic behind each strategy, its results to date, its limitations, and its 
effects on practicing physicians. Our perspective is anchored in our experience at the 
Rochester Individual Practice Association (RIPA) from 1999 through 2006 in producing 
individual-physician performance reports and paying out (since 2002) an average of $15 
million yearly in a pay-for-performance program that operated at the individual-physician 
level. Our pay-for-performance program involved a 3,000-practitioner panel and was 
financed through our risk-withhold dollars (i.e., where a certain amount of each 
participating physician’s fees is withheld and paid out based on the physician’s performance 
on a set of predetermined quality, efficiency, and patient satisfaction measures) to which 
were added shared savings program dollars. The program was based on an HMO member 
base averaging 350,000 members per year in a nine-county service area. The size of the 
membership allowed us to provide profiling reports at the individual physician level. 
 
The goal of each strategy is to increase the value of health care. However, the path 
has proven to be more difficult than imagined. Those from the business community hoping 
to transfer their business techniques to the medical world have been particularly frustrated. 
 
Most current programs employ “judgment” as a principal focus, which means that 
data are being interpreted to create a summative—and subjective—evaluation of a 
physician’s work. In Dr. Jerome’s case, she was “judged” to be 10 percent more expensive 
than her colleagues, which presumably makes her a poorer-performing physician. This 
form of reporting makes a clear, though not necessarily accurate, inference about the 
physician’s relative value. 
 
At the other end of the performance-reporting spectrum is continuous quality 
improvement, in which the physician’s behavior is seen as contributing to a system of 
care. As the system is evaluated for how it delivers services, behaviors that help or hinder 
the attainment of desired outcomes may be identified. By focusing on specific kinds of 
behaviors rather than the value of the individual based on a limited set of inputs, the focus 
remains on the system response to the need to improve rather than on defending one’s 
value, career, or professionalism. 
 
We believe that the current focus on judgment programs has accomplished little 
and will continue to meet with limited success, as these programs ignore some of the more 
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 important lessons that the business community has learned about true quality improvement.4 
In lieu of this focus, we encourage a value paradigm rooted in the core partnership values 
of honesty and respect. Transparency must be delivered not only in the data reported to 
patients and purchasers but also in the processes that health plans use to make decisions 
about physician performance. 
 
Successful transformation of our present system to one based on value requires 
the collaboration of multiple stakeholders. We focus on collaboration because effective 
partnerships are needed to effectively coordinate behaviors, provide a continuum of 
services, and ensure that evidence and patient-centeredness underlie medical decision-
making. The current medical system’s silos must be broken down and replaced with 
integrated programs that encourage and reward effective and efficient system solutions. 
 
EVALUATING CURRENT METHODS TO IMPROVE THE VALUE 
OF CARE 
General Measurement Issues 
Before incentive methods can be evaluated, the validity of the underlying performance-
measurement system must be assessed. We believe that different validity and reliability 
standards apply to different incentive programs, depending on the size, type, and 
importance of the incentive. As the potential consequences of the program increase, the 
requirement for accuracy and validity increases as well.5 Figure 1 displays this relationship 
graphically. As we discuss each of four types of incentive systems, we will touch upon the 
consequences of insufficient accuracy and the perception of validity. 
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 Figure 1. Higher Stakes Require Higher Rigor
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The IOM report Performance Measurement: Accelerating Improvement states that all 
such approaches “depend upon the availability of accurate, reliable, and valid performance 
measures.”6 In addition to these domains we would add attribution of the responsible 
physician(s), assignment of cost, focusing on reaching a target (as opposed to 
improvement), and actionability. 
 
Accuracy 
The current trend in efficiency measurement is to calculate an index of physicians’ costs 
relative to those of their peers. Based on such index results, high-stakes decisions—
determining one physician’s copay relative to others, for example, or inclusion in a “high 
performance network”—may be made. These measures are referred to as efficiency 
indexes, performance factors, or observed-to-expected ratios. 
 
Efficiency indexes are built on the assumption that underlying claims data are 
correct. But in Dr. Jerome’s practice, there are a number of problems with that 
assumption. First, on their visit billing forms, the doctors use disease descriptions but not 
diagnostic codes. For example, they write “depression.” It is John, the billing clerk, who 
determines the actual code number to put on the claim. Billers may do the best they can, 
but they usually do not have clinical training. In this case, John chooses 311.7 This turns 
out to be a very general code in which patients with minor depression, major depression, 
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 psychotic depression, reactive depression, and adjustment disorder with depressed mood 
are included. Because the practice has never received feedback about its coding procedures 
and has no knowledge of how others code, Dr. Jerome and her staff believe their coding is 
appropriate. But, in fact, the distribution of costs of patients within the subclasses of 
depression easily could reflect length of treatment, the need for multiple medications, and 
concurrent psychiatric input. Therefore coding practices could make some cases look 
more or less expensive than average. 
 
In addition, John is paid based on a percentage of charges received. Noting that 
current procedural terminology (CPT) 99214 visits pay $84 while the less comprehensive 
CPT 99213 visits pay $52, he encourages the group to spend a bit more time with each 
patient to maximize revenues (99213 corresponds to 15 minutes, 99214 to 25 minutes).8 
The group has never received feedback on these types of billing practices, much less 
information on how important coding selection is to efficiency scoring. 
 
The accuracy of each health plan’s management of data is also crucial to reporting 
validity. But plan reporting of accuracy auditing is uncommon, if evaluated at all. It is 
becoming increasingly recognized that to be viewed as valid, the accuracy measurements 
should be transparent to the physicians being measured.9 To deal with errors when they 
occur, the reporting organization should outline how one can appeal the corresponding 
decisions, which should also help it prevent errors in the future. For example, until 
brought to the attention of the reporting team, there was considerable inaccuracy in the 
ordering-provider designation both for radiology and pharmacy in our community. 
Inaccurate data should limit the reporting agencies’ confidence in using efficiency indexes 
for high-stakes decision-making regarding financial and nonfinancial incentives. 
 
Attribution 
There are many ways to assign a patient’s costs to a practitioner, whether for population- 
or episode-based measures. Some include: a) the physician who generated the most costs 
for the patient’s care for a particular diagnosis or episode; b) all the physicians who were 
each responsible for a minimum percentage (often 25%) of the episode’s costs; c) all 
practitioners who have filed a claim for the patient; d) the practitioner who sees the 
patient most; and 5) the assigned primary care provider. These attribution models 
determine which costs are assigned to which doctors. 
 
Interestingly, these attribution rules are rarely explained to the practitioners being 
evaluated. In Dr. Jerome’s case, the office assigned the nurse-practitioner Paul to her, so all 
the care Paul delivers is billed under Dr. Jerome, whether she is supervising him in the office 
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 that day or not. In addition, because the doctors all work part-time, they are continuously 
cross-covering each other’s patients. As a result, two of the three doctors usually have less 
than 25 percent of the charges for an episode, so they are excluded from many of the episodes. 
 
Different attribution rules yield significantly different results.10 Therefore it is 
important to know the attribution methodology used in a particular program and to 
understand that methodology’s implications. The National Committee for Quality 
Assurance (NCQA) has proposed standards for cost attribution11 and it requires disclosure 
of such methodology for its Quality Plus Program.12
 
Pham identified a further concern about the accuracy of attribution models.13 In 
examining continuity in Medicare recipients, she found that 33 percent of beneficiaries 
changed assigned physicians from one year to the next, and that only 35 percent of visits 
were to the beneficiary’s assigned physician. Between 2000 and 2002, 46 percent of 
beneficiaries changed or were assigned to a new physician. Pham concluded that “the 
dispersion of patients’ care among multiple physicians will limit the effectiveness of pay-for-
performance initiatives that rely on a single retrospective method of assigning responsibility 
for patient care.” These findings appear to challenge many efficiency determinations, as 
calculating an efficiency score usually requires a minimum two-year data-collection period 
to accumulate sufficient volume of care to create a valid practice assessment. 
 
With the use of efficiency indexes—as part of incentive programs—in its infancy, 
it would seem prudent to determine the effects of several attribution models. Evaluators 
could then choose the one most likely to accomplish a program’s goals before creating 
reimbursement or reporting models that significantly influence a practitioner’s income or 
standing in the community. 
 
Assignment of Cost 
In a program based on episodes of care, efficiency indexes can be calculated from that 
portion of costs directly generated by the physician or from total episode costs. Direct 
costs include office visits to the practitioner, medications prescribed, tests ordered, or 
hospitalizations under his or her care. Total costs are those services generated by the 
practitioner in question plus all the costs generated by other providers during the episode. 
The decision to use directly generated or total costs has important consequences for 
practitioners’ scores as well as ramifications for their uses. 
 
Practitioners reasonably argue that they can only be held accountable for the costs 
that they themselves engender. However, scoring on direct costs creates an incentive to 
make other practitioners order the more expensive interventions. In such a system, the 
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 practitioner can say, “I know how to appear less expensive—I’ll have you do the work.” 
This methodological choice has thus resulted in delays in appropriate care because of 
concerns over who should prescribe chronic medication refills or who should order the 
MRI, as that might worsen an individual’s efficiency score. 
 
Our belief is that total cost is the most appropriate system measure. In this model, 
everyone has an incentive to work together most efficiently and effectively, as all are held 
jointly responsible for the costs of an episode of care. 
 
On the other hand, one of the principles included in most guidelines for 
appropriate performance measurement is that the actions measured be within the control 
of the practitioner.14,15,16
 
One solution to this contradiction might be to use total cost to drive “internal” 
evaluation, as opposed to external evaluation such as public reporting or tiering networks. 
Careful attention to the unintended consequences of each methodological decision, then, 
is a critical step in designing an effective program. 
 
Focusing on Targets or Improvement When Measuring Cost-Efficiency 
There has been considerable debate around whether an efficiency measure should focus on 
achieving a target or a percentage improvement. Those arguing for actually reaching 
targets say that to deliver true quality care, a particular level of care must be assured. 
Therefore, they conclude, one should be rewarded for reaching that target. 
 
Hayward voices an important concern about aiming to reach the target threshold.17 
He argues that if one employs an all-or-none model, the incremental effort to reach the 
target may result in little additional medical benefit while possibly introducing significant 
risk. For example, offering incentives for having all diabetics lower their HbA1c levels to 
less than 6.5 percent raises the risk of hypoglycemic episodes. Similarly, there may be 
unintended adverse effects from increasing drug dosages or ordering additional procedures 
to reach a target. 
 
In another example, there is evidence of potential overuse of the medication 
epoetin by some dialysis programs to ensure patients maintain a hematocrit over 33.18 As 
in the previous case, neither the risks nor benefits of using epoetin specifically when 
hematocrit is close to 33 to reach the target are unknown. 
 
The threshold model is carried even further by Health Partners in Minneapolis, 
which argues that the goal should be satisfying all selected quality measures for certain 
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 clinical conditions.19 Health Partners terms this approach optimal care, and it credits 
providers’ behaviors as such only when all targets for the clinical condition are reached. 
Others, including Donald Berwick of the Institute for Healthcare Improvement, have 
argued for the same approach.20 Although it may work well in ensuring that the steps in 
an accepted process are carried out, the idea that all patients want what the medical 
establishment dictates seems quite paternalistic. 
 
Moreover, providing a reward to a group that is already at or above a target 
accomplishes little. Recently, Young and colleagues found that the best predictor of 
meeting a target was having the highest pre-intervention scores.21 In our experience, the 
payer community justifiably argues against rewarding those who have not improved, given 
that the intent of the incentive is to encourage improved value and outcomes. 
 
As a compromise, a hybrid model seems best for resolving most concerns. A 
system could reward providers for improvement toward the proximity of the threshold, 
using a continuous variable model. Medicare is proposing just such an approach for its 
hospital pay-for-performance program.22 The area in which the provider does the best, be 
it improvement or meeting the target, is reported and serves as the basis for payment. 
 
In Dr. Jerome’s case, she was judged a lower-performing doctor for diabetes care 
after it was determined that her rate of adherence to chronic-disease guidelines was 30 
percent (the target was 65%). She decided that trying to reach a 65 percent target was not 
worth the effort. On the other hand, given a hybrid model, an increase of 50 percent 
would result in a reasonable return and entail an acceptable investment in time and 
money, in her opinion. 
 
Actionability 
It is 3:00 PM on a Saturday afternoon and Dr. Jerome is furiously reviewing records of 
patients whose care makes her cost-inefficient, according to the insurance plan’s analysis of her 
efficiency index. For hypertension her pharmacy costs are high, while for respiratory infections 
her visit costs are high. She reviews the recent guidelines for hypertension and finds that she 
is adhering quite appropriately to the recommendations. That observation, together with what 
she has heard at the many CME programs she has attended, lead Dr. Jerome to believe that 
her medication selections are clinically sound. 
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 As she looks at her notes for respiratory infections, she observes that when adults 
come in for colds, she often uses the visit to find out more about how they are doing 
generally, makes sure recommended screening is being performed, asks about smoking and 
alcohol use, and provides counseling where needed. This approach does generate longer visits, 
which apparently add to her lower cost-efficiency. “So,” she says, “I guess I’ll have folks 
come in separately for their preventive work.” 
 
For efficiency-reporting programs to be successful, they must predictably pinpoint 
practitioners’ overuse and misuse behaviors. Simply providing a global rolled-up measure, 
such as a cost-efficiency index that compares them to a specialty average, is itself 
inefficient. For the busy practitioner, trying to find what to do differently—without the 
proper tools—results in wasted time, frustration, and, eventually, a lack of trust in the 
sponsoring organization.23
 
If practitioners believe they are being evaluated on cost and the incentives are great 
enough, they will reduce service utilization in an effort to improve their scores. 
Unfortunately, in the process they may knowingly or unknowingly reduce both necessary 
as well as unnecessary services, thereby lowering quality. Little work has been done to 
determine how reporting of global scores influences appropriate or inappropriate behavior. 
However, Deming repeatedly noted that exhortations to improve do nothing, and that it 
is management’s job to find the specific actions that improve overall quality.24
 
Rather than judge the individual’s overall performance, a more appropriate goal 
would be to determine the key drivers of unnecessary variations in care for common or 
costly conditions. Then a concerted effort could be made to ensure that necessary services 
are performed and unnecessary ones eliminated for each condition. 
 
PROVIDING INCENTIVES FOR PHYSICIANS TO CHANGE 
In this section, we review the four most common physician-incentive programs currently 
being used in the United States: pay-for-performance, public reporting, consumer-
directed health plans, and tiering/limiting panels. To allow for comparisons between 
them, each discussion addresses the same set of issues: the logic behind the program, 
experience to date, limitations of the program, the practicing-physician perspective, and 
suggested future directions. 
 
Pay-for-Performance 
Logic Behind the Program 
Of all the incentive programs currently deployed in the United States, pay-for-performance 
programs have been most widely used.25 The reasoning behind pay-for-performance is 
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 direct linkage of payment to the performance of designated services. The measures 
selected are intended to evaluate the practitioners’ performance on certain combinations of 
cost, quality, and patient experience of care. Practitioners or medical groups then receive 
incentive payments based on the degree to which they either approach the measures’ 
thresholds or improve their peer ranking for those measures. 
 
Pay-for-performance programs expect that physicians will change their behavior in 
response to sufficient incentives; this model assumes that tying enough dollars to reported 
data will effect the behavioral change. Casalino surveyed general internists and found that 
they supported the concept of being remunerated for providing higher-quality care.26 
Seventy-five percent agreed that if quality measures were accurate, physicians could be 
evaluated and paid for their performance on those measures. That sentiment was recently 
affirmed through focus groups in Rochester, N.Y.27 and in Massachusetts. 
 
Experience to Date 
Although there is growing acceptance of the appropriateness of payment based on 
effectiveness and efficiency of care, so far the evaluation of pay-for-performance programs’ 
influence has been hampered by small incentives, lack of adequate post-intervention 
follow-up, and methodological problems with collecting and reporting the data. Higashi 
et al. have provided some evidence that the use of published targets for selected measures 
results in improved clinical outcomes.28 Both Young and Rosenthal29,30 found minimal 
improvement in quality measures after initiation of pay-for-performance programs. More 
recently, Curtin et al. published the only study to date to evaluate return on investment 
(ROI) for a pay-for-performance program.31 That study demonstrated an ROI of 2.5 for 
the diabetes segment of a larger pay-for-performance program in upstate New York. 
Interestingly, the program demonstrated savings against the yearly trend in the plan’s cost 
of diabetes care per member, even though the pay-for-performance measures focused on 
underuse. These results provide initial evidence that pay-for-performance programs can 
produce a positive ROI, as long as there is careful attention to measure selection, and that 
quality can be improved, with an attendant decreased cost. 
 
Limitations of the Program 
Recent studies have increasingly focused on some of the significant flaws of current pay-
for-performance methodology. However, the consequences of such limitations are of even 
greater concern for the strategies of tiering, public reporting, and limiting panels, as will be 
discussed in later sections of this paper. 
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 Hayward has raised four substantial concerns about pay-for-performance 
programs.32 First, he noted that patient comorbidities influence treatment targets, a 
concern echoed by Pogach.33 An oversimplified outcome measure, be it quality or 
efficiency, in the absence of exclusion criteria and revised targets based on comorbidities 
may cause more harm than good. Second, the benefits of reaching targets are usually 
defined for a subset of patients with a given condition. Analogous to “indication creep” 
for medications and procedures,34 there is a danger of extending the target to others with a 
less severe expression of the condition. Third, the marginal benefit of reaching a target, 
when the practitioner is already near the target, is unstudied; continued pursuit may even 
introduce potentially adverse effects. Fourth, patients able to approach the target—
generally, those with less severe disease—become the more desirable patients; practitioners 
are essentially encouraged to recruit them, while avoiding those who are less likely to 
contribute to reaching the quality or efficiency target. 
 
Finally, a number of organizations have advocated that physicians should be 
evaluated only on measures that are within their control.35,36,37 A number of the measures 
currently in use, including those focusing on cost-efficiency, may be significantly 
influenced by the population being treated or the health beliefs of those drawn to particular 
practitioners. The belief that adherence to a measure should be absolute suggests that the 
decision to proceed with a test or treatment is right or wrong. This dogmatic approach 
significantly limits a patient’s right to choose, a core component of patient-centeredness. 
 
In summary, there is considerable concern that the overly simplistic approach 
currently being taken may mirror an all-too-common error in our medical system: 
implementing a costly and administratively complex program without sufficient evidence 
of its effectiveness. Considerable work is needed to more carefully examine the quality and 
efficiency measures that we impose on practitioners as well as the degree to which we 
ensure that the public is actually well served by our efforts. 
 
Practicing-Physician Perspective 
As noted earlier, physicians are becoming increasingly comfortable with the concept of 
pay-for-performance. On the other hand, there is evidence that they doubt the accuracy 
of current data and distrust the health plans’ motives in promoting the programs.38 The 
degree to which physicians become effectively engaged in the process has much to do 
with the underlying values of the reporting group and the extent of the professional 
community’s participation in the development and maintenance of the program. Our 
experience suggests that physicians pass through predictable stages on the way to 
acceptance of pay-for-performance programs, similar to the stages in the dying process 
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 described by Kubler-Ross.39 Denial is the default coping skill, which is followed by anger, 
bargaining, and, potentially, acceptance. We have suggested that these in fact are the stages 
of coping with any significant change.40
 
When groups reach the bargaining stage, available quality and efficiency measures 
do seem to stimulate changes in behavior. However, some have recently suggested that 
often the level of the individual physician is not the most effective point at which to 
intervene.41 Rather, the practice or system level is more appropriate and leads to greater 
success. Another predictor of success is the degree to which a practice is organized and 
able to hold employees accountable for completing assignments. That observation has 
been supported by the fact that the best predictor of reaching targets is being a high 
performer before the initiation of the program.42
 
Physicians tell us that they want their individual data compared to that of peers. 
They want both quality and efficiency measures that are meaningful, and they especially 
want help in discovering how to improve their performance. In addition, they stress that 
the opportunity to improve should be available before their scores are reported to the 
public or used in judgments about the effectiveness and efficiency of their doctoring. 
 
Future Directions 
We believe that insurers will come to understand that the most productive use of pay-for-
performance programs is in promoting behavioral change for a small set of carefully 
selected measures for which there is ample evidence of need for improvement. Depending 
on the sponsoring organization, the measures can be drawn from the domains of patient 
experience of care, quality, or cost-efficiency. Although there is concern about incentives 
diverting attention from nonselected activities, if the measures are chosen wisely they 
should be those of largest direct benefit to the community. 
 
Critical to pay-for-performance as a quality-improvement program is the reporting 
system that gives feedback to practitioners. We agree with Trude, who argues that the 
most efficient and effective reporting system is one that measures and reports on 
community-wide data.43 There are two reasons for endorsing this approach. First, a single 
reporting system increases the sample size, which makes it robust enough to offer 
meaningful and reliable data. Second, a current problem is that physicians receive 
conflicting reports from multiple plans, which confuses them about what they are 
supposed to be doing.44
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 We also need considerably more research to define how to most effectively design 
a measurement system that captures the intricacies of patient comorbidities and balances 
preservation of individual patient autonomy with improving the population’s health. In 
our view, it is premature to judge the overall quality of a physician based on the available 
information and the lack of evidence on judgments’ accuracy or benefit. We predict that 
in the future, programs that encourage judgment—as opposed to improving community-
wide performance—will be abandoned. 
 
To create effective programs, the providers, purchasers, and insurers will have to 
collaborate more closely. They must establish win–win relationships in order to create 
programs whose incentives are aligned around truly improving the value of care for our 
entire population. 
 
Public Reporting 
The public reporting of health care costs and quality-performance data has long been 
viewed as a tool for improving the health care system’s performance. As far back as 1984, 
CMS reported hospital mortality data publicly.45 In 1990, New York State began 
reporting mortality rates from cardiac surgery.46 After studying this program, Hibbard and 
Jewitt later wrote, “The current approach to health care reform attempts to harness the 
power of consumer choice. Great expectations are being placed on the consumers.”47
 
Logic Behind the Program 
Public reports are designed to drive system change in three ways: using comparison 
data to motivate providers to improve performance, stimulating payers to reward quality 
and efficiency, and providing information to patients so that they can choose their care 
more wisely. 
 
Experience to Date 
Public reporting has met with varied success. Some of the variability is related to the kinds 
of data reported, their mode of presentation, and who they focus on. One of the early 
successes of public reporting was the New York report on cardiac surgery in the early 
1990s,48 followed by similar reports in Pennsylvania. These reports examined mortality 
data by hospital and cardiac surgeon. In New York, over three years there was a 41 
percent decrease in coronary artery bypass graft mortality, thought to be largely the result 
of process improvement in hospitals.49 A consequence of the program, foreshadowing 
concerns in future reporting programs, was the decision of some surgeons to avoid 
providing services to the highest-risk patients.50
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 Although surgeons and their institutions have responded to public reporting, 
purchasers and consumers have not. It appears that the quality improvement derived from 
this program was driven by the hospital’s or surgeon’s desire to improve their public image.51 
Influencing patients’ decision-making appears to require as-yet-unidentified factors. 
 
In another example, Quality Counts—a 2001 report on hospital performance by 
The Alliance, a large employer purchasing cooperative in Madison, Wis.—compared 
performance measures for hospitals receiving no report, hospitals that received their report 
privately, and those whose report was disseminated publicly. Further analysis revealed that 
while both publicly and privately reported hospitals improved significantly compared to 
hospitals not receiving reports, the difference in average performance changes between 
publicly reported and privately reported institutions was not statistically significant.52
 
As in the cardiac surgery experience, the study also found that public reporting 
had little effect on market share; only 4 percent of those exposed to the report used it to 
choose or recommend a hospital. 
 
The Minnesota Community Measurement Project and the Massachusetts Health 
Quality Partners are two other groups actively reporting publicly on performance at the 
medical-group level. At this time, there are no published reports on market-share changes 
attributable to these efforts. But based on its experience with public reporting, Minnesota’s 
Institute for Clinical Systems Improvement (ICSI) has made three observations.53 First, 
public reports supplement organizations’ efforts if the reports also address methods for 
quality improvement. Second, some historical evidence demonstrates that improved 
process and outcomes may be tied to public reporting. Third, there is no evidence that 
consumers and purchasers use performance data to make choices when they purchase 
health care. 
 
CMS is currently starting to promote increased reporting of performance data.54 
At present it is focused on long-term care and home health. In 2007, it is launching 
voluntary physician reporting, with added reimbursement earmarked for those who report 
clinical data. All reported data will be made available to the public. 
 
Limitations 
Many of the limitations of pay-for-performance apply to public reporting as well. A major 
one has been insufficient data to make statistically valid conclusions about any given 
provider. With small sample sizes per provider, it is frequently impossible to determine 
whose performance is different from the average. And because public reporting puts 
 
14
 physicians’ reputations on the line, the professional and emotional stakes are higher than 
with pay-for-performance programs. Providers are likely to increasingly game the system 
to improve score or ranking or to prevent embarrassment. For example, they may avoid 
sicker patients, have others involved in a patient’s care order tests or prescribe medicine, 
or alter visit or procedure coding to shift patients from a more scrutinized condition to a 
less scrutinized one. 
 
The public reporting of performance indexes (cost or quality relative to average) is 
especially problematic. Because most physicians practice in smaller groups with limited IT 
and system design resources, the sharing of best practices in medicine is particularly 
important. But indexes are forced rankings that create an inherent competition, which 
discourages colleagues from actually sharing best practices. 
 
Practicing-Physician Perspective 
As with pay-for-performance, providers’ response to public reports has largely followed 
the predictable emotional response to change.55 The Alliance in Wisconsin, in the initial 
report on its program, clearly described anger and disbelief on the part of hospital staff.56 
In a survey of general internists by Casalino et al. regarding public reporting and pay-for-
performance,57 the majority of respondents were supportive of financial incentives but 
only 45 percent were supportive of group-level reporting, and support decreased to 32 
percent for individual performance. 
 
Maleyeff58 has postulated that one reason for professionals’ resistance to public 
reporting is Deming’s principle of avoiding “management by numbers.”59 Deming speaks 
to individuals’ reward or punishment based on data over which they have little or no 
direct control. This is consistent with ICSI’s observation that individual reports need to be 
connected to actionable improvement. 
 
Massachusetts Health Quality Partners (MHQP) has collaborated with the 
Massachusetts Medical Society (MMS) to better understand how to report data 
successfully. They sponsored eight focus groups with local physicians,60 which showed 
once again that providers were clearly concerned about being evaluated on items outside 
their control. Examples were vaccination refusal based on patient preference and the 
inability to afford a medication copay. 
 
There was also a strong belief that performance data should be shared with those 
physicians being evaluated before the information is distributed to the public. This would 
give them a chance to first improve their scores or outcomes. It was also noted that if the goal 
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 of public reporting truly is improvement, any deficiency noted should be accompanied by 
actionable recommendations on how the individual’s performance might improve. Last, 
practitioners expressed great concern about the unintended consequences mentioned 
earlier regarding cardiac care. If publicly released evaluations are negatively affected by 
sicker or disadvantaged patients, the incentive is to decrease these populations’ access to care. 
 
Future Directions 
It is clear that physicians see the public reporting of their individual quality and cost data as 
very threatening. And their concerns about accuracy, sufficient sample size, and the 
inherent judgment imposed by forced rankings put the intent of public reporting programs 
into question. When added to the fact that patients don’t change their behavior based on 
the released data, the only reason for public reporting appears to be motivating physicians 
to change through fear of humiliation or shame. 
 
Data should of course be available to consumers to allow them to decide from 
whom to seek care and what outcomes they may expect. The challenge, however, is to 
present the data in a way that minimizes the judging of physicians and focuses on 
encouraging quality improvement. Attention to the design and language of public 
reporting programs, and the inclusion of physicians in their development and rollout, will 
determine the efficacy of public reporting on the quality and cost of care. 
 
Consumer-Directed Health Plans 
Consumer-directed health plans (CDHP) are a recent insurance innovation aimed at 
addressing the rising costs of health coverage. The term “consumer-directed health plan” 
is somewhat confusing, as it really refers to many different benefit designs. The central 
concept in all these plans, however, is public reporting combined with a high-deductible 
health plan (HDHP) and tax-advantaged medical spending accounts. 
 
Logic Behind the Program 
All variations of CDHP try to offer consumers broad choices of providers and services, 
coupled with greater information about—and liability for—their prices. In theory, if there 
is access to information on cost, care options, quality, and risks, patients will act as 
informed consumers in a competitive market, helping to manage their costs by taking 
more responsibility for their health care decisions. This model has evolved in direct 
response to concern over the negative cost implications of “moral hazard,” the tendency 
for those not exposed to the cost of care to increase demand and overuse services.61 
CDHP shifts decision-making about the use of services from physicians or plans directly 
to the patient. 
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 At present, a tax-advantaged account is usually either a health reimbursement 
account (HRA) or a health savings account (HSA). HRAs are funded and owned by the 
employer, while HSAs are owned by the employee and are portable between employers. 
HSAs and HRAs differ also in restrictions on funding, qualification, and rollovers, which 
are beyond the scope of this discussion. 
 
The anticipated outcome of the consumer-directed design is that market forces 
will spur innovation, resulting in the delivery of higher-quality and more efficient health 
care. After all, in market economies it is consumer demand that typically drives innovation 
and results in lower prices and improved products. Economic theory holds that even when 
only a relatively small portion of all purchasers actively “shops” for value, the market 
pressure exerted on providers is significant. 
 
Experience to Date 
HSAs, formally established by the Medicare Modernization Act of 2003, have actually 
been part of the tax code since 2001. But as of 2006, only 7 percent of companies offering 
health benefits even offered an HDHP, with or without a savings account.62 Deductibles 
for these plans are five times greater than those of PPOs and 20 times more than HMOs. 
If a subscriber’s deductible exceeds the balance of the savings account, the subscriber may 
be liable for the difference. 
 
The subscriber’s potential costs seem to be a significant barrier to informed-
consumer acceptance of CDHP. This behavior is predicted by Daniel Kahneman’s 
“prospect theory,” which postulates that potential losses are perceived to have greater 
economic impact than potential gains of the same actual monetary value.63 Thus it is no 
surprise that employees chose an HSA consumer-directed plan only 19 percent of the time 
when other options are offered. The majority of employees with an HSA-eligible plan 
(53%) choose it because they have not been offered other plan options. Woolhandler and 
Himmelstein agree, arguing that CDHP may be good for the healthy and wealthy, but 
otherwise it is not to the consumer’s objective advantage to join such a plan.64
 
At this time there is only preliminary data about CDHP. The employer’s total 
premium cost is reported to be less for these plans than for traditional plans, but when all 
medical expenses are calculated, including the savings-account expenses, total costs are 
essentially equal.65 This would characterize cost-shifting rather than cost-reduction. 
Unpublished reports from Mercer, Aetna, and Humana have reported, however, that the 
cost increases in these plans are from one-third to one-half of the average trend in no-
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 HDHP products. Beyond cost to the employer, overall system value cannot be evaluated 
for these plans, given their low market penetration and short duration of use. 
 
Limitations of CDHP 
The limitations of CDHP again include those of pay-for-performance and public 
reporting. Further, CDHP depends on patients’ proper interpretation of reported data, an 
area in which even physicians have difficulty. 
 
Even more important, there is good evidence that patient cost-sharing can actually 
decrease the quality of care.66 The RAND Health Insurance Experiment (HIE) of the 
1970s and 1980s looked at the impact of increasing cost-sharing on care provided. Not 
surprisingly, as patient cost increased, fewer services were used. The most troubling aspect 
of that work was that reductions were equal both for appropriate and inappropriate 
services. Although services avoided by the total study population had little aggregate 
impact on health status, reduced utilization in the subgroup of sick and poor patients 
resulted in inferior outcomes.67
 
A recent study of emergency department (ED) use by patients with HDHPs 
showed similar results.68 Of relevance to this discussion, the decline in ED use for CDHP 
occurred only after an initial visit. It would appear that after the sticker shock of receiving 
the bill, members found alternatives. ED use declined 24 percent overall, with a much 
greater decline in visits categorized as low-severity. However, as in the HIE, patients in 
the lower-income categories experienced a 25 percent reduction in visits for high-severity 
conditions. The implication is that those with fewer financial means in plans with greater 
out-of-pocket exposure begin to behave like the uninsured—that is, they seek less medical 
care than insured individuals do, and have poorer short-term health outcomes. 
 
The differential response to high deductibles—a function of economic status—is 
particularly relevant when looking at CDHP enrollment. Current enrollees have higher 
incomes and appear to be in somewhat better health than those in traditional plans. This 
raises the issue of selection bias, which confounds any studies of the cost benefits of 
CDHP. Moreover, a greater adverse effect on lower-income patients raises the additional 
issue that adoption of CDHP violates the Institute of Medicine principle that health care 
should be socially equitable. 
 
Practicing-Physician Perspective 
Evaluation of physician views on CDHP design has been quite limited. A recent study by 
Pham, which examined how often physicians talked with patients about cost, found that 
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 while discussions on drug cost were quite common, discussions related to testing and care 
setting were infrequent.69 Communication skills retraining will be needed both for office 
staff and practitioners in order to incorporate patients’ questions, in already time-
constrained office visits, about choices of care. 
 
A more fundamental concern about CDHP has been raised by Berenson.70 He 
suggests that CDHP would undermine the tradition of trust between doctor and patient 
and replace it with a vendor model based on “caveat emptor.” 
 
Shifting the fulcrum of the physician–patient relationship to appropriateness of 
resource utilization could dramatically change the use of time in the office visit and, at 
least initially, create role confusion. In the face of data suggesting that needed services will 
be deferred, physicians are deeply concerned. More specifically, they fear that they will 
spend valuable time looking up comparative fees, become more involved in negotiating 
rates, and have higher office expenses as bills are increasingly collected from patient’s 
health savings accounts or out-of-pocket. To many practitioners, this model increases 
rather than decreases system inefficiencies. 
 
Future Directions 
CDHP attempts to impose a structural response to concerns that, in the current health 
care system, no one is motivated to evaluate the true worth of an intervention or to 
eliminate those that do not add value. Speaking in economic terms, the cost of an 
intervention has to be weighed against the value obtained if those funds were spent 
elsewhere. If patients bear responsibility for the actual costs of services, one can argue that 
“moral hazard” will be avoided as they look at the costs and benefits more critically.71
 
The degree to which this model decreases costs and influences utilization has yet to 
be determined. No one has yet assessed the tradeoff between the dollar savings and patient 
harm caused by deferring appropriate care. But for the model to be successful, much work 
will need to be done in training practitioners to integrate cost-effectiveness discussions 
into medical visits and other conversations with patients. A negative impact on the 
processes of care would be an important unintended consequence, which practitioners 
must be vigilant in avoiding. 
 
CDHP relies on market forces to change the system. To the extent that those 
forces are not applicable to health care, CHDP will falter. A market is successful at driving 
value when there are product or service choices, where demand is predictable, and where 
the consumer has the ability to compare. The current system is lacking in all these areas. 
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 Thus for CDHP to really succeed in improving the value of health care, at a 
minimum there needs to be valid and readily accessible information on cost, outcome, and 
risk. We simply do not have that data to give patients at present. As noted above, lack of 
information to make decisions is already a point of enrollee dissatisfaction. Even if data 
were available, it is not known whether patients would be ready to incorporate the 
implications in order to improve care. Tu and May looked at consumer behavior in 
existing self-pay markets where information was readily available and there was relatively 
little time pressure on office visits.72 Despite this best-case scenario, they found that 
patient choices were based largely on referral recommendations rather than objective 
measures. 
 
The continued concerns about affordability and quality will ensure continued 
discussion on how to engage patients in their own care. Value-based insurance design has 
begun to be suggested as an alternative to relying solely on patients to make decisions. 
This model suggests that an individual’s financial liability should not be as large as it is in 
CDHP but based instead on medical evidence that evaluates the relative value of each 
intervention. High-value treatments would have little or no cost to the individual, while 
low-value interventions would have higher costs.73
 
Tiered and Limited Networks 
Logic Behind the Program 
As consumers rejected managed care in the mid-1990s, payers and health plans scurried to 
identify other methods to control their spiraling costs.74 Tiered networks, which were 
designed in response, utilize two mechanisms for controlling cost. The first is to encourage 
patients to switch from high-cost to lower-cost physicians by offering lower copays for lower-
cost physicians or higher copays for higher-cost physicians. The second mechanism is to 
encourage physicians to become more cost-effective in order to avoid the negative outcomes 
of being advertised as a lower-tier physician, with an attendant loss of patients.75,76
 
Experience to Date 
Drapier and colleagues have recently offered a market scan of the early experiences with 
tiering and high-performance networks.77 They report that the most common model uses 
tiered-provider levels with corresponding enrollee cost-sharing differentials (varied copays). 
In a minority of programs, the information is provided to members for information only. 
Most often, plans have targeted specialists for these networks and programs. With little 
evidence of efficacy, the criteria for selection in tiers can be quite varied. Selection is 
confounded by issues related to geographic needs and sociodemographic variables, making 
the validity of the forced rankings suspect. 
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Some plans mix quality and cost measures, while some focus more on cost alone. 
As in the pay-for-performance world, the lack of clarity of purpose may well lead to 
problems. Quality measures that address underuse would increase short-term costs, 
blunting or nullifying the cost-saving effect of efficiency measures. Since there is little 
correlation demonstrating performance on quality and cost measures, as the tiering criteria 
attempt to be more global, the cost saving benefits may be diluted by the addition of 
quality measures into the equations. 
 
However accomplished, the politics of physician selection is a significant 
intervention in the delivery of care. But again, there are no published data on the 
outcomes of these programs. Marketing materials by insurers and consultants encouraging 
such programs suggest savings; however, it seems ironic that programs justifying their 
existence with calls for transparency of cost data have not subjected their methodology and 
results to the very transparency they espouse. 
 
Limitations 
One obvious limitation of these approaches is related to access to providers. The concept 
of limiting access to a subset of providers necessarily implies that there is a pool of excess 
providers from which to choose in that geographical area. This is simply not the case in 
many parts of the country, especially in rural and some inner-city areas. Recent 
evaluations document many areas where physician supply, even without limitations, is 
marginal at best. 
 
The impact of limited access is reflected in problems and compromises of programs 
already implemented. Physicians who normally would be excluded are “invited” onto 
panels that are based not on qualification but on geographic access. Also, once a few 
employers in a community effectively shift patients from “less” to “more” 
effective/efficient providers, those latter providers may fill and need to close their practices 
to all others. Thus the rest of the community is left paying a higher copay to see physicians 
designated as weaker performers. The result is likely to be a large group of unsatisfied 
employees or consumers. 
 
Another problem with this approach is that physicians typically practice in groups. 
But many, including the present authors, have seen as much variation within groups as 
between groups. Difficulties are created, both for patients and physicians, regarding 
whether networks are tiered by group or individual practitioner. If the tiers are created at 
the group level, there will be a regression to the mean and limited potential for results. If 
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 individual physicians are placed in different tiers, patients and practices are hampered by 
disruptions in established patterns of coverage and care. 
 
For example, if Dr. A is a low-copay physician but is away, and a patient used to 
seeing her needs to be seen, the patient may visit with Dr. B, who has a high ($25) copay 
rather than the customary top-tier copay of $10. Worse, imagine a physician assistant who 
is supervised by physicians in different tiers. If the patient sees the physician assistant on, 
say, Dr. B’s day rather than Dr. A’s day, does he or she pay the higher copay for seeing the 
same person? 
 
From the technical perspective, there is considerable concern that measures used to 
define effective/efficient physicians are neither valid nor reliable enough to make such 
important judgments.78 Current measures are quite limited and are complicated by several 
factors: a lack of data to demonstrate the benefits of making treatment decisions that may 
cause only minor changes in scores,79 the absence of a broad set of measures to examine 
the depth and breadth of a physician’s care, and the relative absence of measures to assess 
the quality of a practitioner’s patient-centeredness. 
 
For example, even if a physician’s diabetes and cost scores are excellent, how does 
one also factor in his or her availability for urgent needs, willingness to see patients outside 
of office hours, and capacity to respond to the grief and sorrow of coping with significant 
illness? As we focus on “hard” measures, we have yet to determine what effect that has on 
the other aspects of the care process. 
 
Even if all such measures were perfected, physician performance falls on a bell-
shaped curve. There are relatively few outstanding physicians and equally few poor ones. 
Trying to influence the behavior of those in the middle risks tampering with the system 
by moving patients based on chance events. Deming argues that such interventions 
actually increase variation in performance.80
 
Practicing-Physician Perspective 
So far, tiering has been met with significant physician dissatisfaction. In St. Louis and 
Washington State, physician organizations sued insurers, who later rescinded their 
programs.81,82 In Massachusetts, physicians have protested tiering methodologies through 
the Massachusetts Medical Society. Concerns are focused on a number of issues 
highlighted earlier, including inaccurate data, unreliable cost measures, the absence of 
meaningful risk adjustment, and the use of measures on which the physician has minimal 
influence.83 The lack of data justifying the intervention, combined with the highest stakes 
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 of any of the programs discussed in this paper, has thus led to significant pushback by the 
physician community. 
 
Physicians’ major criticisms of tiering programs are both technical and 
interactional. Provided with any detailed information behind their scores, physicians 
quickly recognize the technical limitations described above. Tiered systems inherently 
violate principles of relationship-centered administration, which have been shown to be a 
key in physician engagement and quality improvement.84,85
 
The other aspect of the physician community’s response is an interpersonal one. 
These views are summed up by the comments of four Massachusetts physicians, obtained 
during the previously mentioned focus groups sponsored by MHQP and MMS and 
conducted by Dr. Beckman These comments are published with permission of both 
organizations.86
 
Physician 1: I don’t think anyone minds the game when the game is supposedly to 
improve the quality of care. If there is a game to improve the quality of care, sign me 
up, I’ll play that game. But when the game is unfair, and the rules are all askew, 
that is where the problem is. If you can fix it to make the data real, bring it on. 
Physician 2: Whenever I purchase something, I do a lot or research. Either 
Consumer Reports or Amazon because the information is reliable, it’s reproducible 
and from an independent body, not the manufacturer. The problem with the quality 
measures with insurers, the measures are good but the person doing it sometimes 
has an incentive that sometimes conflicts and that’s the concern we have as 
physicians. It’s not credible and it doesn’t take into account the other variables. 
Physician 3: Good care, we say, is inexpensive care. If the patient does well and 
gets out of the hospital quickly, that’s more inexpensive than someone who does 
poorly. The system does deserve to have its money used efficiently. I don’t think we 
are as efficient in this country as we can be with the utilization of our resources and I 
guess that’s what it’s all about. But it certainly shouldn’t be punitive and we should 
all be involved in the way it’s decided, and maybe that’s why we are here tonight. 
Physician 4: They (the physician hospital organization) are now taking the step to 
meet with specialists and actually show them data on the rates of their surgical 
outcomes. We see numbers. When you see yourself at the bottom of the list, you 
try and work your way up. 
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 Generally, the focus-group physicians were disheartened and angered by what 
appeared to them to be an undeserved attack on individual physicians who had little 
advance notice of the impending assault, and, more important, no opportunity to improve. 
 
Such feelings were mirrored as well in Drapier and colleagues’ summary of early 
experiences.87 Their conversations with practitioners identified the following concerns 
about the tiering model: lack of communication from the plans about the program; being 
uninformed about their designations within the high-performance system; plans’ lack of 
explanation about how performance was assessed; unavailability of data that would help 
drive improvement; the accuracy and reliability of available data; insufficient sampling size on 
which to base these important decisions; and the lack of standardization in methodologies 
(a practitioner might be in different tiers for different plans). United’s experience in St. Louis 
and Regence’s experience in Washington State have been the two most visible examples 
of physician pushback against these programs.88,89
 
Future Directions 
The future for tiering and limited panels is not at all clear at the present. As noted, this 
approach is not useful in most small and medium-sized markets, where there is no pool 
of excess physician capacity; and it is methodologically problematic in all markets, 
whatever their size. Some may argue, however, that even when used for small numbers 
of practitioners, the impact will be surprisingly great because of practitioners’ fear of 
being publicly chastised or excluded from a panel. 
 
To date, these programs have not provided physicians with the information 
needed to improve their performance. As a result, it is difficult to imagine how significant 
savings will be achieved. And a potentially greater problem is that, in the absence of 
meaningful information, physicians will reduce both necessary and unnecessary services 
as part of a more generic cost-cutting response. 
 
Tiered networks combine the highest stakes with the most difficult technical 
issues, and at a time when the measures available to make the determinations of value 
are inadequate for the task. Adding the effects of such a highly judgmental model on 
physicians’ sense of professionalism and work satisfaction, we believe that the future 
of tiered networks is quite limited. 
 
CONCLUSIONS 
As long as the costs of care continue to escalate, payers will keep searching for strategies to 
successfully control their health care cost trend. Their urgent need to decrease costs draws 
them to simple, far-reaching programs such as pay-for-performance, public reporting, 
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 consumer-directed health plans, and tiered networks. All such programs have some 
intuitive attractiveness. Pay-for-performance reflects the idea that “you get what you 
pay for.” And it seems logical to direct patients to the more efficient effective physicians 
through public reporting, the application of consumer incentives, or simply eliminating 
lower-scoring practitioners from a network. 
 
Unfortunately, in the field of medicine, as in other complex human endeavors, 
the path to improved quality is strewn with simple logical concepts that failed. The lack 
of demonstrated efficacy, the problems with trying to identify the precise qualities of a 
physician that lead to predictable increases in health care value, and the inherently 
judgmental nature of all these interventions suggest that they are unlikely to fulfill their 
expectations. For example, the judgmental nature of tiered and limited networks, together 
with the high stakes of such interventions, suggests especially strong physician resistance. 
 
An examination of these approaches’ less-than-glowing results leads us to the 
conclusion that, in the health care industry, basing change on the foundation of win–lose 
relationships does not work (Figure 2). To successfully transform the health care system 
for producing greater value, we need to organize it by agreeing on fundamental principles 
and focusing on a clear set of goals. There is no question that as a nation we have to find 
a successful strategy to improve the value of care we provide. But so far, the challenge 
has been to align the key stakeholders rather than simply transfer dollars from one silo 
to another. 
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 Figure 2. The Win–Lose Cycle
Source: H. B. Beckman, Rochester Individual Practice Association, Mar. 2004.
No feedback loop. Costs dip briefly, then escalate.
Providers withhold innovations, ideas.
They spend time imagining how to beat the system.
Practitioners seek loopholes, alternatives.
Develop mechanisms to reduce costs.
Payers Plans
 
 
To succeed, the perspectives of providers, consumers, payers, and insurers have 
to be elicited and then molded into programs that respect all participants. Moreover, 
each group must be held accountable for its performance in achieving the desired health 
outcomes and financial results. 
 
It is important, as we look to create a more effective and efficient system, that we 
not mistake programs to force behavioral change with a successful quality-improvement 
process. What is more, attempts to externally impose motivation through the use of 
incentives have had very mixed results; indeed, they have spawned their own set of 
problematic behaviors.90 The key to success is to have motivational methodology that 
works synergistically with a continuous quality-improvement process. 
 
In our view, tiering and high-performance networks, and even poorly designed 
public reporting programs, fail to meet these criteria. These programs require the 
identification of winners and losers, but all practitioners are essential to maintaining access 
to the system. Creating a population of physicians who feel humiliated and disrespected, 
yet still have to help support the system, is a recipe for disaster. We are beginning to see 
that outcome playing out in a number of communities already. 
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 Consumer-directed health plans have theoretical strengths, but they are years away 
from creating sufficient data and delivering it in an understandable format. The reality, for 
the time being, is that we will be asking medically naïve consumers to use inadequate data 
to drive decisions that are difficult even for their more experienced and knowledgeable 
physicians. Pretending that the reason for promoting these programs is informed choice is 
simply irresponsible. CDHP is being promoted to shift costs, pure and simple. 
 
Pay-for-performance has the potential to be part of the solution, for two reasons: 
improvement can be built into the performance program, and robust data systems can help 
practitioners identify specific behaviors that may be causing their inefficiency or lower 
quality. The risks of employing pay-for-performance programs lie in the degree to which 
they default to judgment programs and attempt to determine who are the “best” and 
“worst” physicians. Rather, pay-for-performance should carefully determine the key foci 
that require change in a given community at a given time. Those foci should become the 
measures selected, and results should be reported to the public, payers, and providers. To 
the degree that pay-for-performance programs promote improvement, offer actionable 
feedback, and encourage the reduction of overuse, underuse, and misuse, they will 
improve the care process. 
 
In the final analysis, Dr. Jerome, like almost all of her colleagues, wants to be 
reasonably compensated for providing high-quality and cost-effective care. She will feel 
engaged and respected if she is offered accurate and valid data about her patient population, 
clear guidance about what to change in order to be considered a better practitioner, and 
specific action items regarding how to improve. Given such a win–win relationship and 
effective leaders, the medical community will be an active and enthusiastic participant in 
transforming our health care system. 
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 RECOMMENDATIONS 
General Measurement Issues 
Accuracy 
• Health plans should report internal accuracy-audit results to evaluated 
practitioners. 
• Reporting organizations should outline how one can appeal decisions based 
on inaccurate data and prevent future errors. 
• Informational programs should be developed for practitioners so that they 
understand the methodology of efficiency indexing and can ensure accurate 
data inputs. 
 
Attribution 
• Evaluated practitioners should be informed of the attribution methodology 
used by plans to determine efficiency scores. 
• For Medicare patients, individual physician-efficiency scoring should be 
abandoned until concerns regarding continuity issues are resolved. 
• Determine the effects of several attribution models and then choose the one 
most likely to accomplish a program’s goals. This should be done before 
creating reimbursement or reporting models that significantly influence 
practitioners’ income or community standing. 
 
Assignment of cost 
• Evaluated practitioners should be informed of the cost methodology employed 
by plans to determine efficiency scores. 
• To promote collaboration and a sense of combined responsibility for patients’ 
care, total episode costs—as opposed to direct costs—should generally be used 
for determining a physician’s or physician group’s efficiency. 
 
Focusing on targets versus improvement 
• Evaluated practitioners should be informed if a target, improvement, or a 
hybrid of both is the criterion. 
• A hybrid is preferred, and the proposed Medicare hospital methodology 
should be used as a model. 
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 Actionability 
• Determine the key drivers of unnecessary variation in care for common or 
costly conditions within a specialty. Then make the reduction of that variation 
a goal of the reporting program. 
• Incentivize practitioners to reduce unnecessary variation by specifically 
identifying overuse behaviors and modes of behavioral change. 
 
Providing Incentives for Physicians to Change 
Pay-for-performance (Note: Recommendations do not imply endorsement of these 
programs by the authors or The Commonwealth Fund.) 
• Pay-for-performance programs to motivate behavioral change should be based 
on a small set of carefully selected measures. They should be employed only 
when there is ample evidence of, and agreement among all stakeholders about, 
the need for improvement. 
• Develop methods to address patient severity. 
• Provide compensation based on improvement as well as on reaching a target. 
Employ continuous variables for payment so as to discourage incremental 
treatment in pursuit of minimal clinical improvement. 
• Ensure that measures address the correct organizational level. Report at the 
individual-physician level when the desired outcome is within the control of 
the physician and the measure is clinically meaningful. 
• Measure performance based on community-wide data. 
 
Public reporting 
• Report only accurate and audit-proven data to the public. It is not appropriate 
to use vendors’ black-box technology without audited results. 
• Data should be reported to physicians well in advance of reporting to the 
public. In that way, inaccuracies and flawed scoring methodologies can be 
identified and corrected before physicians are publicly judged. 
• Reported measures should be actionable at the provider level, or at whatever 
level is most appropriate. Efficiency indexes and other roll-up models are too 
inaccurate to use for high-stakes reporting. 
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 Consumer-directed health plans 
• At least initially, do not market CDHP to low-income families or to patients 
with complex medical problems. 
• Before expanding CDHP to consumers/employees, improve the quality of 
data and the transmission of information. 
• Before purchasing CDHP, members should undergo communication-skills 
training and be educated about the use of data and their role in this new 
model of decision-making. 
• Given already time-constrained office visits, practitioners and staff will need 
to be trained to address patients’ questions about choices of care. 
 
Tiered and limited networks 
• Exempt physicians in underserved areas and underpopulated specialties from 
the tiering process. 
• Develop pilot programs to ensure that there are sufficient accuracy of selection 
and actual returns to warrant the effect on professionals’ lives and careers. 
• Quality and patient-experience-of-care measures should be included in the 
data set that determines tier and network membership. 
• Tiering programs should only be implemented after physicians have been 
apprised of the measures to be used and given a reasonable period of time 
to improve their performance. 
• Tiers should be based on absolute performance—not on forced rankings— 
so that all who achieve the desired level of performance can receive credit. 
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